Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03435484 · ClinicalTrials.gov registry record · NA
Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.
A NA study of Patient Reported Outcomes, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 27,263
- Enrollment target
- 1
- Study location
NCT03435484: Completed NA study of Patient Reported Outcomes, sponsored by NYU Langone Health.
NCT03435484 is a NA study of Patient Reported Outcomes that has completed, run by NYU Langone Health. The registered enrollment target is 27,263 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1843% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03435484, a NA study of Patient Reported Outcomes, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 27,263 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patient-reported health outcomes.
Primary Outcome
Completion rate data is routinely collected by the medical center.
Conditions Studied
Interventions
- OTHER Arm A
- OTHER Arm B
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,263 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03435484 record still lists
NCT03435484 is an interventional study that assigns participants to a tested intervention. Its 27,263 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1843% higher).
The record links to 1 condition, with Patient Reported Outcomes appearing as the primary indexed condition, and to 2 interventions - of which Arm A is the first listed.
NCT03435484 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03435484 about?
NCT03435484 is a clinical study titled "Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.". The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patien...
What is the current status of trial NCT03435484?
This trial is currently completed. It is a NA study. The enrollment target is 27,263 participants. The study started on 2018-02-07. Estimated completion is 2019-05-31.
What conditions does trial NCT03435484 study?
This clinical trial studies the following conditions: Patient Reported Outcomes.
What interventions are being tested in trial NCT03435484?
The interventions under investigation include: Arm A (OTHER), Arm B (OTHER).
Who is sponsoring clinical trial NCT03435484?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03435484 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Reported Outcomes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03435484's enrollment target sits among peer trials
27,263 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI